Dyax's Unattributed VC Round

Dyax raised a round of funding on November 19, 1998.

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to…

Articles about Dyax's Unattributed VC Round: